Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • U vs MRNA✓SelectedUSD · MRNAU vs MRNA performance historyLatest closeAs of-1.76%11/16
Stock and ETF performance explorer

U vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+77.7%
MRNA return
+179.0%
Excess return
-101.4%
Maximum drawdown
-67.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.8%-3.6%+1.9%-1.6%
7D+0.9%-20.0%+20.8%+2.1%
30D+28.4%-1.3%+29.7%+28.2%
3M+12.2%+240.0%-227.8%-1.2%
6M+91.0%+339.0%-248.0%+57.7%
YTD+17.5%+630.0%-612.5%-14.8%
1Y+41.3%+769.1%-727.8%-1.9%
All+77.7%+179.0%-101.4%+29.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling